VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 75 filers reported holding VYNE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $376,000 | – | 54,938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 2,670,000 | $1,736,000 | 0.60% |
| GSA CAPITAL PARTNERS LLP | 236,292 | $154,000 | 0.02% |
| BAILARD, INC. | 139,381 | $91,000 | 0.00% |
| Tekla Capital Management LLC | 135,395 | $88,000 | 0.00% |
| DELTEC ASSET MANAGEMENT LLC | 30,000 | $20,000 | 0.00% |
| TOBIAS FINANCIAL ADVISORS, INC. | 11,000 | $7,000 | 0.00% |
| STALEY CAPITAL ADVISERS INC | 62,500 | $41,000 | 0.00% |
| Virtu Financial LLC | 24,601 | $16,000 | 0.00% |
| Renaissance Technologies | 965,098 | $627,000 | 0.00% |
| CSS LLC/IL | 25,264 | $16,000 | 0.00% |